PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

GILD-Q123-Earnings-Presentation-27-April-2023 - Gilead Biosciences | Presentation Nation

HomepageGilead BiosciencesGILD-Q123-Earnings-Presentation-27-April-2023

GILD-Q123-Earnings-Presentation-27-April-2023

Gilead Biosciences

Browse presentations, reports, and documents from Gilead Biosciences.

Tags

2023

Filter options

All (48)●
brochure (11)○
infographic (1)○
presentation (35)○
report (1)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

GILD-Q123-Earnings-Presentation-27-April-2023 by Gilead Biosciences.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Gilead Biosciences

AMS_CaseStudies_Gilead_FINAL

brochure

CASEstudy_LS_pharma_Gilead_FINAL

brochure

Similar presentations from other companies

Delek US Holdings_November_2017_486_17486

presentation

Delek US Holdings

A-REIT_Investor-Presentation-Aug2016-3

presentation

Ascendas Funds Management Limited

Cell%20and%20Gene%20ISPE%20SD%204-25-19%20Full%20Day%20Class%20Flyer

brochure

Client-Story-Gilead-Science-Ireland

presentation

EVOKE-02

report

gild-jpm-2024-presentation-8-january-2024

presentation

Commonwealth Bank of Australia_August_2018_178_32178

presentation

Commonwealth Bank of Australia

Baxter International_July_2021_324_72324

presentation

Baxter International

Global Blood Therapeutics_May_2020_208_55208

presentation

Global Blood Therapeutics

Miragen Therapeutics_June_2019_51_43051

presentation

miRagen Therapeutics